CD57+, a global marker of immunosenescence, is elevated in an atypical cohort of patients with Kaposi sarcoma and well-controlled HIV

Authors

Keywords

Journal

Volume 4, Issue Suppl 2, Pages P43

Publisher

Springer Nature

Online

2009-06-18

DOI

10.1186/1750-9378-4-s2-p43

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now